Serial Number
99037289
Owner
Flagship Labs 103, Inc.Attorney
Christina M. LicursiFiling Date
Feb 11, 2025
EXOLENS Trademark
Serial Number: 99037289
Trademark Classes
Owner Contact Info
55 Cambridge Parkway, Suite 800E
Cambridge, MA 02142
Entity Type: 03
Legal Representation
Correspondence Address
Christina M. Licursi Wolf, Greenfield & Sacks, P.C.
600 Atlantic Avenue
Boston, MA 02210-2206
United States
Trademark Details
Filing Date
February 11, 2025
Registration Date
Not Registered
Published for Opposition
November 11, 2025
Goods & Services
Pharmaceutical research and development; scientific and medical research and development in the field of computational biology, bioinformatics, genomics, biotechnology, diagnostics, and pharmaceuticals; temporary use of online, non-downloadable software for drug development, namely, software for cellular diagnostic and research systems and for cellular isolation and analysis; temporary use of online, non-downloadable software in the nature of a drug discovery platform, namely, software for cellular diagnostic and research systems and for cellular isolation and analysis; temporary use of online, non-downloadable software in the nature of a diagnostic platform used to isolate, fractionate, and interrogate cells as diagnostics; technical scientific consultation and product development for others in the field of biotechnology and the development of pharmaceuticals and therapeutics; research and development in the field of computational biology, bioinformatics, genomics, biotechnology, diagnostics, and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development in the field of computational biology, bioinformatics, genomics, biotechnology, and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for cellular diagnostic and research services; platform as a service (PAAS) featuring computer software platforms for cellular isolation and analysis; platform as a service (PAAS) featuring computer software platforms to isolate, fractionate, and interrogate cells as diagnostics; all of the foregoing excluding optics and electro-optics and related services